GB0906068D0 - Bisphosphonate Compounds for chelating radionuclides - Google Patents

Bisphosphonate Compounds for chelating radionuclides

Info

Publication number
GB0906068D0
GB0906068D0 GBGB0906068.2A GB0906068A GB0906068D0 GB 0906068 D0 GB0906068 D0 GB 0906068D0 GB 0906068 A GB0906068 A GB 0906068A GB 0906068 D0 GB0906068 D0 GB 0906068D0
Authority
GB
United Kingdom
Prior art keywords
bisphosphonate compounds
chelating radionuclides
radionuclides
chelating
bisphosphonate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0906068.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kings College London
Original Assignee
Kings College London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kings College London filed Critical Kings College London
Priority to GBGB0906068.2A priority Critical patent/GB0906068D0/en
Publication of GB0906068D0 publication Critical patent/GB0906068D0/en
Priority to PCT/GB2010/000692 priority patent/WO2010116132A2/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/662Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0474Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0489Phosphates or phosphonates, e.g. bone-seeking phosphonates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839Polyphosphonic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/58Pyridine rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0906068.2A 2009-04-07 2009-04-07 Bisphosphonate Compounds for chelating radionuclides Ceased GB0906068D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0906068.2A GB0906068D0 (en) 2009-04-07 2009-04-07 Bisphosphonate Compounds for chelating radionuclides
PCT/GB2010/000692 WO2010116132A2 (en) 2009-04-07 2010-04-07 Bisphosphonate compounds for chelating radionuclides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0906068.2A GB0906068D0 (en) 2009-04-07 2009-04-07 Bisphosphonate Compounds for chelating radionuclides

Publications (1)

Publication Number Publication Date
GB0906068D0 true GB0906068D0 (en) 2009-05-20

Family

ID=40750292

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0906068.2A Ceased GB0906068D0 (en) 2009-04-07 2009-04-07 Bisphosphonate Compounds for chelating radionuclides

Country Status (2)

Country Link
GB (1) GB0906068D0 (en)
WO (1) WO2010116132A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201306627D0 (en) 2013-04-11 2013-05-29 Thompson Richard Marker
TWI609875B (en) * 2015-04-20 2018-01-01 聚和國際股份有限公司 Compound for bone scanning and use thereof
US11253614B2 (en) 2016-08-23 2022-02-22 University Of Maryland, Baltimore Methods for detecting and/or predicting age-related macular degeneration and/or Alzheimer's disease
CN107655871A (en) * 2017-09-12 2018-02-02 重庆医科大学 A kind of highly sensitive wide detection range fluoroscopic examination new method of Alendronate sodium

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3623397A1 (en) 1986-07-11 1988-01-14 Boehringer Mannheim Gmbh NEW DIPHOSPHONIC ACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
US5190930A (en) 1987-12-11 1993-03-02 Ciba-Geigy Corporation Araliphatylaminoalkanediphosphonic acids
PL1656386T3 (en) 2003-08-21 2010-05-31 Sun Pharmaceuticals Ind Ltd A process for preparation of bisphosphonic acid compounds

Also Published As

Publication number Publication date
WO2010116132A3 (en) 2011-05-12
WO2010116132A2 (en) 2010-10-14

Similar Documents

Publication Publication Date Title
IL213992A0 (en) Pro-neurogenic compounds
IL215147A0 (en) Compounds
GB0907425D0 (en) Compounds
EP2393493A4 (en) Compounds
ZA201203662B (en) Compounds
IL213019A0 (en) Azaazulene compounds
GB0914856D0 (en) Compounds
GB0919194D0 (en) Compounds
GB0915892D0 (en) Compounds
GB0922302D0 (en) Compounds
GB0909671D0 (en) Compounds
ZA201200093B (en) 3-phenoxymethylpyrrolidine compounds
GB0906068D0 (en) Bisphosphonate Compounds for chelating radionuclides
GB0915519D0 (en) Ntithrombotic compounds
AP2909A (en) Pyrazinoisoquinoline Compounds
GB0911000D0 (en) Compounds
TWM370827U (en) Exposure machine
GB0905057D0 (en) Compounds
GB0918473D0 (en) Compounds
GB0910008D0 (en) Compounds
GB0910123D0 (en) Compounds
GB0910675D0 (en) Compounds
GB0908942D0 (en) Compounds
GB0913248D0 (en) Compounds
GB0914594D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)